Healthcare & Life Sciences Review Portugal 2024 – drawing from over 30 interviews with key stakeholders from industry, government, academia, and hospitals – paints a picture of a nation and a sector not without its challenges, but gradually carving out some highly promising niches. Topics covered in this comprehensive and up-to-date new report include deep…
Country Reports
Morocco, and its healthcare sector, have reached a pivotal moment. The North African nation is currently implementing the most ambitious, far-reaching, and comprehensive health system reorganization in its history along with a major shake-up of the regulatory frameworks governing the country’s local pharmaceuticals industry. All of this is occurring within the context of a cross-industry…
Long considered a destination of choice for life science multinationals seeking to tap into the latent potential of Middle Eastern markets, the United Arab Emirates’ pharmaceuticals, medtech and healthcare sectors have all been exhibiting significant growth momentum in the post-pandemic period. This comprehensive new report, based on interviews with government officials, KOLs, representatives of multinational…
Legal & Regulatory
The Pharma Legal Handbook: Czech Republic answers essential questions about the legal and regulatory environment for pharmaceuticals in the Czech Republic. It is a must-have for any company operating in the country or looking to enter the market. Prepared in association with PRK Partners, a leading Czech law firm, it should answer any questions linked to regulation,…
The Pharma Legal Handbook: India answers essential questions about the legal and regulatory environment for pharmaceuticals in India. It is a must-have for any company operating in the country or looking to enter the market. Prepared in association with Nishith Desai Associates, a leading Indian law firm, it should answer any questions linked to regulation,…
Ready to tap into the EUR 4.7 billion Dutch pharma market? The Pharma Legal Handbook: The Netherlands is your key to unlocking this strategically positioned and flourishing market.The Netherlands isn’t just about a robust pharma market; it’s a hub of top-notch institutions, including the European Medicines Agency, world-class healthcare, and a thriving start-up culture. Add…
InFocus
InFigures
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2023 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings, innovation footprints, IPOs, and drug approvals, as well as market-specific executive insight from the PharmaBoardroom archives, this exclusive new report is an excellent jumping-off point…
PharmaBoardroom’s latest report, InFigures: Middle East & Africa (MENA) 2022 features up-to-date datasets from the region’s leading pharma markets and regional production hubs. MENA may be the smallest pharmaceutical market in the world, accounting for just 2 percent of world market, but it has seen remarkable growth over the last few years and is estimated…
PharmaBoardroom’s latest report, InFigures: European Pharma Hotspots 2022 features up-to-date datasets from six major European pharma hubs. Europe is the world’s second biggest pharma market region and boasts the headquarters of some of the world’s largest pharma companies. Despite this, in recent years the region has lagged behind both North America as well as East…